Terms: = Liver cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Diagnosis
24 results:
1. TBACkp: HER2 expression status classification network focusing on intrinsic subenvironmental characteristics of breast cancer liver metastases.
Yang K; Song J; Liu M; Xue L; Liu S; Yin X; Liu K
Comput Biol Med; 2024 Mar; 170():108002. PubMed ID: 38277921
[TBL] [Abstract] [Full Text] [Related]
2. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study.
Shao G; Fan Z; Qiu W; Lv G
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16489-16499. PubMed ID: 37712961
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
5. A gadoxetic-acid enhancement flux analysis of small liver nodules (≤2 cm) in patients at high risk of hepatocellular carcinoma.
Chen H; Wang J; Guo T; Ye T; Wan J; Sun P; Pan F; Yang L
Eur J Radiol; 2023 Aug; 165():110911. PubMed ID: 37300937
[TBL] [Abstract] [Full Text] [Related]
6. Research on Predicting the Occurrence of Hepatocellular Carcinoma Based on Notch Signal-Related Genes Using Machine Learning Algorithms.
Zhou D; Cao S; Xie H
Turk J Gastroenterol; 2023 Jul; 34(7):760-770. PubMed ID: 37051625
[TBL] [Abstract] [Full Text] [Related]
7. Distinct radiological features of lymphoepithelioma-like intrahepatic cholangiocarcinoma: comparison with classical intrahepatic cholangiocarcinoma.
Liu LH; Wang ML; Jiang F; Chen LL; Ji Y; Zeng MS
Abdom Radiol (NY); 2023 Jun; 48(6):2038-2048. PubMed ID: 37004556
[TBL] [Abstract] [Full Text] [Related]
8. Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma.
Wang F; Liu H; Bai Y; Li H; Wang Z; Xu X
J Clin Lab Anal; 2021 Nov; 35(11):e24025. PubMed ID: 34569662
[TBL] [Abstract] [Full Text] [Related]
9. Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for diagnosis of Bile Duct cancer: A Meta-Analysis.
Yoon SB; Moon SH; Ko SW; Lim H; Kang HS; Kim JH
Dig Dis Sci; 2022 Jul; 67(7):3284-3297. PubMed ID: 34263382
[TBL] [Abstract] [Full Text] [Related]
10. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.
Jiang D; Yuan X; Ni J; Shen L; Cai M; Xu L
Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Wang G; Lu X; Du Q; Zhang G; Wang D; Wang Q; Guo X
Sci Rep; 2020 Aug; 10(1):13519. PubMed ID: 32782270
[TBL] [Abstract] [Full Text] [Related]
12. Second cancers in MPN: Survival analysis from an international study.
Marchetti M; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Cacciola R; McMullin MF; Tieghi A; Recasens V; Isfort S; Pane F; De Stefano V; Griesshammer M; Alvarez-Larran A; Vannucchi AM; Rambaldi A; Barbui T
Am J Hematol; 2020 Mar; 95(3):295-301. PubMed ID: 31816122
[TBL] [Abstract] [Full Text] [Related]
13. Effect of surgical delay on survival outcomes in patients undergoing curative resection for primary hepatocellular carcinoma: Inverse probability of treatment weighting using propensity scores and propensity score adjustment.
Kabir T; Syn N; Ramkumar M; Yeo EYJ; Teo JY; Koh YX; Lee SY; Cheow PC; Chow PKH; Chung AYF; Ooi LL; Chan CY; Goh BKP
Surgery; 2020 Feb; 167(2):417-424. PubMed ID: 31677800
[TBL] [Abstract] [Full Text] [Related]
14. Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study.
Yu J; Ding WB; Wang MC; Guo XG; Xu J; Xu QG; Yang Y; Sun SH; Liu JF; Qin LX; Liu H; Yang F; Zhou WP
Int J Cancer; 2020 Mar; 146(6):1754-1763. PubMed ID: 31456215
[TBL] [Abstract] [Full Text] [Related]
15. Large Cell Neuroendocrine Carcinoma of the Extrahepatic Bile Duct.
Park JY; Jeon TJ
Korean J Gastroenterol; 2018 Dec; 72(6):318-321. PubMed ID: 30642152
[TBL] [Abstract] [Full Text] [Related]
16. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract] [Full Text] [Related]
17. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
[TBL] [Abstract] [Full Text] [Related]
18. Rapid on-site evaluation using telecytology: A major cancer center experience.
Lin O; Rudomina D; Feratovic R; Sirintrapun SJ
Diagn Cytopathol; 2019 Jan; 47(1):15-19. PubMed ID: 29575752
[TBL] [Abstract] [Full Text] [Related]
19. Evolution of hepatocellular carcinoma epidemiology in Côte d'Ivoire.
Didi-Kouko Coulibaly J; Yeboua M; Kouassi Mbengue A; Kouadio EA; Anzouan-Kacou Kissi H; Binan AY; Lohoues Kouacou MJ; Attia A; Yao DNA; Toutou T; Adoubi I; Pineau P
Bull Cancer; 2017 Nov; 104(11):937-945. PubMed ID: 29128083
[TBL] [Abstract] [Full Text] [Related]
20. [Surgical treatment of liver haemangiomas in a third level hospital in south-east Mexico].
Ortiz-Bayliss AB; Martínez-Mier G; Alvarado-Arenas RA; Lajud-Barquín FA
Cir Cir; 2016; 84(6):477-481. PubMed ID: 27131977
[TBL] [Abstract] [Full Text] [Related]
[Next]